President Trump's Drug Pricing Policy and Pharma Stocks
Policy shifts around president trump's drug pricing could squeeze pharma profits and shift stock dynamics. This guide...
Benchmarks provide objective yardsticks to assess results, set expectations, and keep portfolios aligned with objectives.
19,836 articlesPolicy shifts around president trump's drug pricing could squeeze pharma profits and shift stock dynamics. This guide...
Insiders are weighing a bold scenario where SpaceX could climb to as much as $10 trillion by 2030, potentially overta...
A new State of AI report finds openai’s lead over other AI labs has largely faded as competitors close the gap, resha...
A landmark NYC case shows how a nonprofit steered funds through hidden vendors, inflating costs and obscuring ownersh...
A drone strike lit a cargo ship off Qatar, testing a fragile Iran ceasefire. UAE and Kuwait reported drone incursions...
Crypto traders are pricing SpaceX ahead of any IPO using Hyperliquid's SPCX-USDC contract, with early data suggesting...
Retail investors face shrinking net returns as private equity fees compress gains. A timely look at Jeff Hook’s blunt...
A UN FAO economist warns that fertilizer shortages and rising energy costs could push global food prices higher withi...
Mega-cap IPOs from SpaceX and Anthropic are approaching, potentially reshaping index fund rules and 401(k) allocation...
Bitcoin sits in a bitcoin deep value zone as on-chain signals show ongoing selling pressure from long-term holders. T...
Meta unveils Muse Spark 1.1, touting stronger coding and multimodal abilities as it accelerates its AI push led by Al...
A leading AI-focused ETF is spreading risk across 86 stocks and delivering outsized gains, challenging the dominance ...